USD 72.51
(-0.3%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 9.15 Billion USD | 0.18% |
2023 | 9.13 Billion USD | 0.75% |
2022 | 9.07 Billion USD | 1.7% |
2021 | 8.91 Billion USD | 23.96% |
2020 | 7.19 Billion USD | 11.7% |
2019 | 6.44 Billion USD | -10.91% |
2018 | 7.23 Billion USD | -9.38% |
2017 | 7.97 Billion USD | 9.06% |
2016 | 7.31 Billion USD | -4.26% |
2015 | 7.64 Billion USD | -9.18% |
2014 | 8.41 Billion USD | -6.51% |
2013 | 9 Billion USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q3 | 8.89 Billion USD | 2.02% |
2024 Q2 | 8.71 Billion USD | 2.89% |
2024 Q1 | 8.46 Billion USD | -7.33% |
2024 Q4 | 9.15 Billion USD | 2.99% |
2023 Q3 | 9.33 Billion USD | -1.17% |
2023 Q4 | 9.13 Billion USD | -2.13% |
2023 FY | 9.13 Billion USD | 0.75% |
2023 Q1 | 9.29 Billion USD | 2.42% |
2023 Q2 | 9.44 Billion USD | 1.71% |
2022 Q1 | 9.28 Billion USD | 4.09% |
2022 FY | 9.07 Billion USD | 1.7% |
2022 Q4 | 9.07 Billion USD | -3.06% |
2022 Q3 | 9.35 Billion USD | -1.65% |
2022 Q2 | 9.51 Billion USD | 2.47% |
2021 Q1 | 7.55 Billion USD | 4.93% |
2021 Q3 | 8.59 Billion USD | 6.8% |
2021 Q4 | 8.91 Billion USD | 3.83% |
2021 FY | 8.91 Billion USD | 23.96% |
2021 Q2 | 8.04 Billion USD | 6.53% |
2020 Q3 | 6.8 Billion USD | -0.27% |
2020 Q4 | 7.19 Billion USD | 5.77% |
2020 FY | 7.19 Billion USD | 11.7% |
2020 Q1 | 6.31 Billion USD | -2.02% |
2020 Q2 | 6.82 Billion USD | 8.08% |
2019 Q3 | 6.52 Billion USD | -0.04% |
2019 FY | 6.44 Billion USD | -10.91% |
2019 Q4 | 6.44 Billion USD | -1.23% |
2019 Q2 | 6.52 Billion USD | -5.86% |
2019 Q1 | 6.93 Billion USD | -4.14% |
2018 FY | 7.23 Billion USD | -9.38% |
2018 Q3 | 7.09 Billion USD | -1.98% |
2018 Q4 | 7.23 Billion USD | 1.97% |
2018 Q1 | 8.04 Billion USD | 0.86% |
2018 Q2 | 7.23 Billion USD | -10.11% |
2017 FY | 7.97 Billion USD | 9.06% |
2017 Q1 | 7.33 Billion USD | 0.28% |
2017 Q2 | 8.7 Billion USD | 18.65% |
2017 Q3 | 8.11 Billion USD | -6.76% |
2017 Q4 | 7.97 Billion USD | -1.7% |
2016 FY | 7.31 Billion USD | -4.26% |
2016 Q4 | 7.31 Billion USD | 0.14% |
2016 Q3 | 7.3 Billion USD | 0.28% |
2016 Q2 | 7.28 Billion USD | -5.12% |
2016 Q1 | 7.67 Billion USD | 0.48% |
2015 FY | 7.64 Billion USD | -9.18% |
2015 Q4 | 7.64 Billion USD | -6.0% |
2015 Q3 | 8.13 Billion USD | 1.23% |
2015 Q2 | 8.03 Billion USD | -0.57% |
2015 Q1 | 8.07 Billion USD | -4.0% |
2014 FY | 8.41 Billion USD | -6.51% |
2014 Q4 | 8.41 Billion USD | 0.03% |
2014 Q3 | 8.41 Billion USD | 0.59% |
2014 Q2 | 8.36 Billion USD | -1.44% |
2014 Q1 | 8.48 Billion USD | -5.74% |
2013 Q4 | 9 Billion USD | -12.89% |
2013 Q3 | 10.33 Billion USD | 0.23% |
2013 Q2 | 10.3 Billion USD | -1.52% |
2013 Q1 | 10.46 Billion USD | 0.0% |
2013 FY | 9 Billion USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Phreesia, Inc. | 371.08 Million USD | -2367.359% |
Accuray Incorporated | 468.62 Million USD | -1853.793% |
Align Technology, Inc. | 6.08 Billion USD | -50.496% |
Elevance Health Inc. | 108.92 Billion USD | 91.594% |
AxoGen, Inc. | 196.82 Million USD | -4551.801% |
Boston Scientific Corporation | 35.13 Billion USD | 73.941% |
CVS Health Corporation | 249.72 Billion USD | 96.334% |
Cardinal Health, Inc. | 45.12 Billion USD | 79.708% |
Centene Corporation | 84.64 Billion USD | 89.183% |
DaVita Inc. | 17.61 Billion USD | 48.035% |
HCA Healthcare, Inc. | 56.21 Billion USD | 83.711% |
Humana Inc. | 47.06 Billion USD | 80.546% |
IDEXX Laboratories, Inc. | 3.25 Billion USD | -180.865% |
Laboratory Corporation of America Holdings | 16.72 Billion USD | 45.256% |
Masimo Corporation | 3.04 Billion USD | -201.036% |
McKesson Corporation | 67.44 Billion USD | 86.424% |
Patterson Companies, Inc. | 2.96 Billion USD | -208.38% |
Quest Diagnostics Incorporated | 14.02 Billion USD | 34.703% |
ResMed Inc. | 6.87 Billion USD | -33.229% |
Henry Schein, Inc. | 10.57 Billion USD | 13.402% |
Teladoc Health, Inc. | 4.39 Billion USD | -108.452% |
Universal Health Services, Inc. | 14.35 Billion USD | 36.226% |
Veeva Systems Inc. | 5.91 Billion USD | -54.9% |
Baxter International Inc. | 28.27 Billion USD | 67.619% |
Becton, Dickinson and Company | 52.78 Billion USD | 82.653% |
Intuitive Surgical, Inc. | 15.44 Billion USD | 40.705% |
Danaher Corporation | 84.48 Billion USD | 89.163% |
Stryker Corporation | 39.91 Billion USD | 77.06% |
Medtronic plc | 89.98 Billion USD | 89.825% |